Drug Type ASO |
Synonyms SAMSSONrx Flamingo Therapeutics |
Target |
Action inhibitors |
Mechanism SAMMSON inhibitors(survival associated mitochondrial melanoma specific oncogenic non-coding RNA inhibitors), Epigenetic drug, RNA interference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Uveal Melanoma | Preclinical | Belgium | - |